Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Leukemia, Lymphoid
>>
AKT inhib
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
perifosine
(D21266) / AEterna Zentaris
Estybon
(rigosertib) / Onconova, SymBio Pharma, Knight Therap
MK-2206
/ Merck (MSD)
afuresertib
(LAE002) / Laekna Therap
